A Trial of Sertraline in Young Children With Autism Spectrum Disorder

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions

Autism Spectrum Disorder

Interventions

DRUG

Sertraline Liquid Placebo

Liquid placebo given in parallel to active medication

DRUG

Sertraline

Active medication

Trial Locations (1)

UC Davis MIND Institute, Sacramento

All Listed Sponsors

collaborator

Health Resources and Services Administration (HRSA)

FED

lead

Randi J. Hagerman, MD

OTHER

NCT02385799 - A Trial of Sertraline in Young Children With Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter